Archive: 21st Century Dermatopathology: Molecular Diagnostics for Melanocytic Neoplasms
Melanocytic tumors of uncertain malignant potential (MelTUMPs) and other borderline melanocytic neoplasms have long posed a significant challenge to pathologists and clinicians, and expose patients to under- or over-treatment and surveillance, thus leading to significant anxiety. The World Health Organization 4th Edition (2018) reclassified melanocytic tumors into nine “pathways” on the basis of not just histomorphology but initiating and driver mutations, and introduced benign (i.e., nevus), intermediate (i.e., melanocytoma), and malignant classifications for each of the traditional phylogenies of melanocytic tumors. Next-generation sequencing (NGS) has allowed for identification of initiating driver mutations, as well as secondary genomic alterations known to be important to melanomagenesis, and has allowed for improved classification and prognostication of the biologic behavior of borderline melanocytic neoplasms. We will discuss several such cases from the University of Washington Dermatopathology service with the aim of highlighting the importance of uniting histopathologic and molecular data in modern dermatopathology. After viewing this lecture, participants should be able to: 1. Recognize important initiating and progressive genomic events in benign and malignant melanocytes 2. Understand “melanocytomas” (formerly known as MELTUMP or STUMP) as intermediate grade melanocytic neoplasms 3. Identify situations in which the use of next-generation sequencing and other molecular diagnostic techniques can help classify melanocytic tumors Ata Moshiri, MD, MPH Assistant Professor Department of Medicine, Division of Dermatology Department of Laboratory Medicine and Pathology University of Washington 03/02/22 The University of Washington is committed to ensuring digital accessibility in our services, programs, and activities. If you encounter accessibility barriers using videos found on this channel, please contact UW Video at uwvideo [at] uw [dot] edu.

Archive: Advancing practice at the intersection of molecular diagnostics and surgical pathology

Deep penetrating and combined nevi Phi;;ip McKee, Michael Cardis, George Balis

LRR Microbiology for FMGE 2026 By Dr. Preeti Sharma

Melanocytic Dermpath Basics: Benign Nevus

How Melanoma Develops: Causes and Pathology

#DERMPATH MELANOMA: FROM CLINICAL PRESENTATION TO MOLECULAR DIAGNOSIS

S13 E17: Trump’s Reflecting Pool, Redistricting & Soaps: 6/28/26: Last Week Tonight with John Oliver

Sign-Out with the Professor- Mole or Melanoma? Cracking the Code on Problematic melanocytic lesions

Malformations & Mosaicism: Role of Oncogenic Variants & Genetic Complexity in Developmental Lesion

Spitz Nevus, Dysplastic Nevus, Blue Nevus, Congenital Nevus & more - Dermatopathology Basics

#DERMPATH How to Diagnose Borderline Cutaneous Melanocytic Lesions

New Concepts in IBD Pathology

Genetics and Melanoma: A Closer Look

Molecular Testing Basics in 15 minutes (molecular pathology FISH NGS Next Gen cancer genetics DNA)

Why Evolution Split Your Brain In Half – Brain Asymmetry with Jim Al-Khalili

Dermatopathology: The Molecular Basis of Melanoma w/ Dr. Desman

Spitz Nevi & Spitzoid Melanocytic Lesions

Squamous Cell Carcinoma & Actinic Keratosis 101...Dermpath Basics & Beyond

This Common Food Is Feeding Your Cancer Cells - Dr. William Li

